Results for cancer: 202

* Abraxane worked better than Sanofi's Taxotere * Drug 'nearly doubled' progression-free survival CHICAGO, May 26 - Abraxane, a new cancer drug designed to be less toxic than standard chemotherapy, did a better job of...

* 41 pct improvement in progression-free survival * OSI CEO sees $500 mln opportunity with new approval * 10-fold benefit seen in EGFR mutation patients NEW YORK, May 14 - Lung cancer drug Tarceva was...

LOS ANGELES, May 14 - A genetic test that predicts whether colon cancer will return in certain patients will have a significant impact on treatment options, researchers said on Thursday. Molecular diagnostics company Genomic Health...

*Test shows 71 pct of patients with mutation benefit *Could return Iressa to US market WASHINGTON, May 14 - A test that looks for a certain mutation in tumors can predict which lung cancer patients...

WASHINGTON, May 8 - New warnings have been added to Genentech Inc and OSI Pharmaceutical Inc's cancer drug Tarceva about serious complications such as skin reactions and holes in the digestive tract, U.S. health regulators...

* Avastin cleared for most agressive brain cancer * Accelerated approval following early studies ZURICH, May 6 - The U.S. Food and Drug Administration has granted accelerated approval for Roche Holding's Avastin drug for the...

* Provenge improved 3-year survival by 38 percent * Provenge patients lived 4.1 months longer on average * No major adverse events seen with Provenge in study NEW YORK, April 28 - An experimental cancer...

* U.S. study finds statin use linked with lower cancer risk * Statins also associated with other urological benefits * Findings preliminary, further clinical trials needed LONDON, April 26 - Cholesterol-lowering statin drugs may protect...

* Misses main target in trial for early stage colon cancer * Success would have brought major boost for key Roche drug * Roche bought Genentech to benefit from Avastin sales * Roche shares fall...

* Success could have brought major sales boost * Roche bought out Avastin developer Genentech last month ZURICH, April 22 - A late-stage trial of cancer drug Avastin has shown that it does not prevent...